Overview

The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia

Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the therapeutic effect of escitalopram in the treatment of negative symptoms in schizophrenia patients in a double-blind placebo-controlled study.
Phase:
Phase 3
Details
Lead Sponsor:
BeerYaakov Mental Health Center
Collaborator:
Lundbeck Israel
Treatments:
Citalopram
Dexetimide